Endometrial adenocarcinomas displayed two main signatures that were characteristic of the proliferative phase endometrium, SOX9+LGR5+ and SOX9+LGR5−, indicating differences in pathogenesis and disease progression. Here, SOX9 is linked to endometrium adenocarcinoma.